Asthma Market Research Reports & Industry Analysis
The strongest risk factors for developing asthma are a person’s exposure to allergens and a family history of asthma or allergy. Exposure to tobacco smoke and exposure to chemical irritants in the workplace are additional risk factors. Workplace conditions, such as exposure to fumes, gases or dust, are responsible for 11% of asthma cases worldwide.
Asthma Industry Research & Market Reports
-
Asthma Treatment Drugs Markets in China
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines ... Read More
-
Asthma Treatment Drugs Industry Forecasts - China Focus
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Asthma Treatment Drugs Companies in China
... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More
-
Global Nebulizers, Inhalers And Respirators For Asthma Treatment Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... Asthma Treatment market research report provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical ... Read More
-
Asthma Therapeutics
... growing at a CAGR of 2.3% over the analysis period 2023-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end ... Read More
-
Global Pulmonary Drug Delivery Devices Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... By End-user, By Region, and Segment Forecasts, 2023 – 2030 Global Pulmonary drug delivery devices market was valued at US $35.6 Billion in 2022 and is expected to reach US $48.5 Billion by 2030, growing ... Read More
-
Global COPD and Asthma Devices Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market ... Read More
-
Asthma Spacers Market - forecast to 2033 : By PLACEHOLDER TYPE OF SPACER (Aerochambers, Optichambers, Inspirease, Volumatic, Others), PLACEHOLDER MATERIAL (Plastic, Metal, Silicon, Others), PLACEHOLDER AGE GROUP (Adults, Children), PLACEHOLDER END-USER (Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers, Others), PLACEHOLDER APPLICATION (COPD, Asthma, Others), PLACEHOLDER TECHNOLOGY (Regular Spacers, Breath-actuated Spacers, Others), PLACEHOLDER FEATURES (Anti-static, Transparent, Compact & Portable, Others), and Region
... Homecare Settings, Ambulatory Surgical Centers, Others), PLACEHOLDER APPLICATION (COPD, Asthma, Others), PLACEHOLDER TECHNOLOGY (Regular Spacers, Breath-actuated Spacers, Others), PLACEHOLDER FEATURES (Anti-static, Transparent, Compact & Portable, Others), and Region The Asthma Spacers market is an integral ... Read More
-
Asthma Spacers
... growing at a CAGR of 2.7% over the analysis period 2023-2030. Aerochamber Spacer, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$508.7 Million by the end ... Read More
-
Digital Dose Inhalers
... Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$4.4 ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Treatment
... in the year 2023, is expected to reach US$27.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Combination Drugs, one of the segments analyzed in the report, is expected ... Read More
-
Severe Asthma - Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Home Healthcare Market, By Product & Services (Product (Diagnostics and Monitoring Home Devices, Therapeutics Home Healthcare Devices, Mobility Assist Devices, Medical Supplies) and Services (Rehabilitation Services, Telehealth and Telemedicine Services, Infusion Therapy Services, Respiratory Therapy Services, Unskilled Home Healthcare Services)), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders, Neurological & Mental Disorders, Respiratory Disease & COPD, Maternal Disorders, Mobility Disorders, Cancer, Wound Care, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Therapy Services, Unskilled Home Healthcare Services)), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders, Neurological & Mental Disorders, Respiratory Disease & COPD, Maternal Disorders, Mobility Disorders, Cancer, Wound Care, Others), By Geography (North ... Read More
-
Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Instruments and Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F
... Diagnostic Test, Molecular Diagnostic Tests), By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others), By Region and Competition, 2019-2029F Global Respiratory Diagnostics Market was ... Read More
-
Global Eosinophilic Asthma Treatment Competitive Landscape Professional Research Report 2024
... characterized by elevated levels of eosinophils, a type of white blood cell, in the airways. This treatment typically involves the use of inhaled corticosteroids and other anti-inflammatory medications to reduce airway inflammation, bronchodilators to alleviate ... Read More
-
Breath Analyzer Market by Technology (Fuel Cell Technology, Infrared & Smart Crystal, Semiconductor Oxide Sensor Technology), Application (Alcohol Detection, Asthma Detection, COVID-19 Test), End User - Global Forecast 2024-2030
... was estimated at USD 2.91 billion in 2023 and expected to reach USD 3.15 billion in 2024, at a CAGR 8.42% to reach USD 5.12 billion by 2030. Breath analyzers are analytical devices used to ... Read More
-
Pulmonary Drugs Market by Drug Class (Anti-Cholinergic Agents, Anti-Leukotrienes, Antihistamines), Indication (Allergic Rhinitis, Asthma, Chronic Obstructive Pulmonary Disease), Drug Type, Distribution Channel, End-User - Global Forecast 2024-2030
... at USD 79.35 billion in 2023 and expected to reach USD 86.14 billion in 2024, at a CAGR 8.03% to reach USD 136.27 billion by 2030. The pulmonary drugs market encompasses a wide range of ... Read More
-
Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Global Forecast 2024-2030
... and expected to reach USD 114.55 billion in 2024, at a CAGR 7.53% to reach USD 177.94 billion by 2030. Pediatric healthcare is a branch of medicine pertaining to the provision of medical care to ... Read More
-
Respiratory Care Devices Market by Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Disease), End-User - Global Forecast 2024-2030
... at USD 19.87 billion in 2023 and expected to reach USD 21.08 billion in 2024, at a CAGR 6.39% to reach USD 30.66 billion by 2030. The respiratory care devices market encompasses various medical devices, ... Read More
-
Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 18.60 billion in 2024, at a CAGR 8.11% to reach USD 29.75 billion by 2030. Eprazinone is a mucolytic and expectorant medication utilized in the treatment of ... Read More
-
Allergic Asthma due to Dermatophagoides Farinae – Market Insight, Epidemiology, and Market Forecast – 2034
... in-depth understanding of the Allergic Asthma due to Dermatophagoides Farinae, historical and forecasted epidemiology as well as the Allergic Asthma due to Dermatophagoides Farinae market trends in the United States, EU5 (Germany, Spain, Italy, France, ... Read More
-
Eosinophilic Asthma – Market Insight, Epidemiology, and Market Forecast – 2034
... forecasted epidemiology as well as the Eosinophilic Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Eosinophilic Asthma market report provides current treatment practices, emerging drugs, ... Read More
-
Asthma Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... 36.73 billion by 2029, growing at a CAGR of 5.88% during the forecast period (2024-2029). Factors such as an increase in the incidence and prevalence of asthma, the growing geriatric population, and technological advancements are ... Read More
-
Respiratory Devices Market, By Product Type (Respiratory Consumables, Nebulizers, Oxygen Concentrators, Positive airway pressure devices, Polysomnography Devices, Pulse Oximeters, Mechanical Ventilators, and Spirometers), By Indication (Chronic Obstructive Pulmonary Disease, Asthma, Acute Respiratory Infections, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The global respiratory devices market has been witnessing significant growth in ... Read More
-
Venturi Masks
... growing at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end ... Read More
Research Assistance
